Eric Mascellino, DPM
Primary Podiatric Medicine · Miami, FLNPI 1609438282
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.4% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Smith+Nephew at 28.8% of the total. Reporting peaked in 2023 at $483 and has fallen 74.7% since, to $122 in 2025.
Across 58 payments — averaging $30.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$504
- Osteomed LLC$300
- Paragon 28, Inc.$273
- Aroa Biosurgery Incorporated$172
- Integra Lifesciences Corporation$122
- Stryker$64
- plus $314 from 10 others
What the payments were for
- Food & beverage$1,60091%
- Education$1519%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 31 | $504 |
| Osteomed LLC | 3 | $300 |
| Paragon 28, Inc. | 2 | $273 |
| Aroa Biosurgery Incorporated | 3 | $172 |
| Integra Lifesciences Corporation | 6 | $122 |
| Stryker | 1 | $64 |
| Zimmer Biomet | 2 | $59 |
| Treace Medical Concepts, Inc. | 2 | $57 |
| Derma Sciences, Inc. | 1 | $39 |
| Organogenesis Inc. | 1 | $32 |
| ETS Wound Care LLC | 1 | $27 |
| Bioventus LLC | 1 | $23 |
| Dynasplint Systems Inc. | 1 | $21 |
| Bone Support Inc. | 1 | $21 |
| KCI USA, Inc. | 1 | $18 |
| Sanara Medtech Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$250
- GRAFIX PL$111
- BIO-Cal Phos$106
How this compares
$1,751 in reported general payments places this provider in the 70th percentile of 68 primary podiatric medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 289 | $4,084 |
| Ciclopirox | 105 | $2,681 |
| Clotrimazole | 73 | $830 |
| SsdSilver Sulfadiazine | 26 | $441 |
| Ketoconazole | 12 | $313 |
| Mupirocin | 39 | $244 |
| Triamcinolone Acetonide | 19 | $240 |
| Silver Sulfadiazine | 23 | $132 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Miami
- Richard MercadoMiami$10K
- Allan FreedlineMiami$310
- Christopher SwartzMiami$93
- Robert SnyderTamarac$623K
- Melissa VerdeLongwood$257K
- Kevin LapoffGreenacres$64K
- Beth PearceSt Augustine$27K
- Dmitry SandlerHialeah$11K
- Gladys de LeonOrlando$8K
- Tanika HarlisPort Saint Lucie$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.